1. Perinatal Outcomes of Non-Primary Maternal Cytomegalovirus Infection: A 15-Year Experience
- Author
-
Maria Grazia Capretti, Alessandra Curti, Antonio Farina, M. Contoli, Giuliana Simonazzi, Francesca Cervi, Brunella Guerra, Nicola Rizzo, Liliana Gabrielli, Tiziana Lazzarotto, and Simonazzi G, Curti A, Cervi F, Gabrielli L, Contoli M, Capretti MG, Rizzo N, Guerra B, Farina A, Lazzarotto T.
- Subjects
0301 basic medicine ,Embryology ,medicine.medical_specialty ,Time Factors ,Ultrasound scan ,Congenital cytomegalovirus infection ,Cytomegalovirus ,Disease ,Ultrasonography, Prenatal ,Serology ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Avidity ,030212 general & internal medicine ,Pregnancy Complications, Infectious ,Retrospective Studies ,Congenital cytomegalovirus infectionNon-primary infectionUltrasound scan ,Fetus ,Obstetrics ,business.industry ,Infant, Newborn ,Obstetrics and Gynecology ,Retrospective cohort study ,General Medicine ,medicine.disease ,Infectious Disease Transmission, Vertical ,Cytomegalovirus infection ,Treatment Outcome ,030104 developmental biology ,Cytomegalovirus Infections ,Pediatrics, Perinatology and Child Health ,Immunology ,Female ,business ,Follow-Up Studies - Abstract
Objective: To evaluate perinatal outcomes in case of non-primary maternal cytomegalovirus (CMV) infection. Methods: We performed a retrospective cohort study of pregnant women with active CMV infection referred to our unit over a 15-year period (January 2000 to December 2014). Non-primary infection was diagnosed on the basis of the results of confirmatory serological and virological tests (avidity test, immunoblotting, real-time PCR-DNA). The vertical transmission rate and the percentage of symptomatic congenital infection were determined in this group of patients. Results: A total of 205 pregnant women were enrolled. Congenital infection occurred in 7 (3.4%) fetuses/neonates. Symptomatic disease was present at birth in 3 of the 7 congenitally infected neonates (1.5%). Two out of 3 symptomatic newborns presented a pathologic second-trimester ultrasound scan. Conclusion: Maternal immunity offers substantial protection against intrauterine transmission of CMV infection, but not against disease once the fetus is infected.
- Published
- 2017
- Full Text
- View/download PDF